The FDA has called BS on CVM's attempt to paint some failed trial as sufficient for approval and sayign CVM needs to run a proper trial and show positive results from that to get an approval.
And somehow that means the DCVax-L failed trial is worthy of approval?
There is a reason why Dr Liau says she hopes patients can access -L via Right-to-Try or such while waiting for trials to prove or disprove efficacy.